Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



New Painkiller Banned: Massachusetts Fallout

Zoegenics' (NASDAQ: ZGNX  ) Zohydro has been contentious since well before its approval by the FDA. After all, the FDA's advisory committee voted overwhelmingly against approval -- and the FDA then approved the drug despite that vote! The drug is indicated for the management of pain sufficiently severe to require around-the-clock daily opioid treatment for the long term, when other treatment options are insufficient.

Since its approval last year, members of Congress, 28 attorneys-general, and most recently Massachusetts Governor Deval Patrick have weighed in against the drug, citing concerns about the drug not being tamper proof -- and therefore open to abuse. In late March, Governor Patrick issued an executive order declaring a state of emergency in Massachusetts regarding heroin and opiate addiction and banning sales of Zohydro in the commonwealth.

This week, Zoegenics challenged the executive order in court, with CEO Roger Hawley saying that "we are convinced the decision [to ban Zohydro] was driven by factual inaccuracies about the science and the data." A ruling is expected soon from District Court Judge Rya Zobel, who noted (per the Boston Globe) that "I think, frankly, the governor is out of line on this."

In this video from Tuesday's Market Checkup, Motley Fool health care analysts David Williamson and Michael Douglass discuss Zohydro and what's next for the embattled painkiller and its parent company.

3 stocks poised to be multi-baggers
Looking for stocks with the growth opportunity but without all the bad press? The one sure way to get wealthy is to invest in a groundbreaking company that goes on to dominate a multibillion-dollar industry. Our analysts have found multi-bagger stocks time and again. And now they think they've done it again with three stock picks that they believe could generate the same type of phenomenal returns. They've revealed these picks in a new free report that you can download instantly by clicking here now.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 16, 2014, at 5:02 PM, mpr120 wrote:

    How about each atty gen and senators and that fat pig of a governor are open for tampering in other words money talks to get what you want.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2909682, ~/Articles/ArticleHandler.aspx, 8/28/2015 2:06:25 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Michael Douglass

As the Motley Fool's Health Care Editor/Analyst, I focus on all things health care -- although my greatest interest is in the megatrends reshaping the American health care system, including the Affordable Care Act, Accountable Care Organizations, a shifting regulatory landscape, and the new drug discoveries fundamentally changing disease management and treatment.

Today's Market

updated 4 hours ago Sponsored by:
DOW 16,654.77 369.26 2.27%
S&P 500 1,987.66 47.15 2.43%
NASD 4,812.71 115.17 2.45%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/27/2015 3:59 PM
ZGNX $17.06 Up +0.52 +3.11%
Zogenix, Inc. CAPS Rating: ***